Cargando…
Oncolytic viruses in melanoma
Malignant melanoma recurrence remains heterogeneous in presentation, ranging from locoregional disease (i.e., local recurrence, satellites, in transit disease) to distant dermal and visceral metastases. This diverse spectrum of disease requires a personalized approach to management and has resulted...
Autores principales: | Robinson, Camille, Xu, Maria M, Nair, Smita K, Beasley, Georgia M, Rhodin, Kristen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888358/ https://www.ncbi.nlm.nih.gov/pubmed/35227006 http://dx.doi.org/10.31083/j.fbl2702063 |
Ejemplares similares
-
Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
por: Sarver, Melissa, et al.
Publicado: (2021) -
Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis
por: Therien, Aaron D., et al.
Publicado: (2022) -
Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice
por: Rhodin, Kristen E., et al.
Publicado: (2022) -
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
por: Kimpel, Janine, et al.
Publicado: (2018) -
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma
por: Andtbacka, Robert H.I., et al.
Publicado: (2019)